BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26448011)

  • 1. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis.
    Luo Y; She DL; Xiong H; Fu SJ; Yang L
    Medicine (Baltimore); 2015 Oct; 94(40):e1670. PubMed ID: 26448011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
    Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
    BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
    Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Su L; Zhang M; Zhang W; Cai C; Hong J
    Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.
    Mjaess G; Chebel R; Karam A; Moussa I; Pretot D; Abi Tayeh G; Sarkis J; Semaan A; Peltier A; Aoun F; Albisinni S; Roumeguère T
    Acta Oncol; 2021 Jun; 60(6):704-713. PubMed ID: 33586577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
    Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
    World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
    Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
    Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
    Li J; Cheng Y; Ji Z
    Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.
    Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J
    PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of NLR in urinary cancers: a meta-analysis.
    Wei Y; Jiang YZ; Qian WH
    PLoS One; 2014; 9(3):e92079. PubMed ID: 24642859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
    BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Cao J; Zhu X; Zhao X; Li XF; Xu R
    PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.
    Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J
    Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
    Lu Y; Jiang J; Ren C
    PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
    Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
    PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis.
    Zhou Y; Li D; Lin Y; Yu M; Lu X; Jian Z; Na N; Hou B
    Onco Targets Ther; 2018; 11():2489-2496. PubMed ID: 29760558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.